Fate of antibody to interferon (IFN) in chronic hepatitis C patients treated with recombinant IFN alpha 2 and retreated with lymphoblastoid IFN alpha

被引：9
|
作者：
Antonelli, G
Giannelli, G
Currenti, M
Simeoni, E
Milella, M
Schiraldi, O
Dianzani, F
机构：
[1] UNIV ROMA LA SAPIENZA,INST VIROL,I-00185 ROME,ITALY
[2] UNIV PISA,DEPT BIOMED,I-56100 PISA,ITALY
[3] UNIV BARI,INST MED CLIN 2,BARI,ITALY
[4] UNIV BARI,INST INFECT DIS,BARI,ITALY
来源：
INTERNATIONAL HEPATOLOGY COMMUNICATIONS | 1995年 / 4卷 / 04期
关键词：
interferon alpha; antibodies to interferon; hepatitis C virus; chronic hepatitis C infection; resistance to interferon therapy; interferon therapy;
D O I：
10.1016/0928-4346(95)00251-0
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Eight chronic hepatitis C patients treated with recombinant interferon (rIFN) alpha 2 developed neutralising antibodies against it, and lost response to therapy. After 6 months of follow-up, the treatment was switched to lymphoblastoid IFN alpha and clinical response was restored. The presence of neutralising antibodies to IFN in the sera of these patients was examined during the follow up and during the retreatment with the natural IFN alpha preparation. The results showed that in most of the patients antibodies to IFN alpha 2 disappeared very rapidly during the follow-up period and did not rise again when the patients were retreated with a different commercial preparation of IFN alpha.
引用
收藏
页码：232 / 237
页数：6
相关论文
共 50 条
  • [21] Evaluation of IFN gamma and TNF alpha gene expression in chronic hepatitis C (CHC) patients treated with interferon alpha and ribavirin.
    Leroy, V
    Dufeu-Duchesne, T
    O'Brien, C
    Jouvin-Marche, E
    Golden-Mason, L
    O'Farrelly, C
    Marche, P
    Zarski, JP
    [J]. HEPATOLOGY, 2004, 40 (04) : 457A - 457A
  • [22] MULTICENTER RANDOMIZED TRIAL WITH RECOMBINANT INTERFERON ALPHA-2B (IFN) IN THE TREATMENT OF CHRONIC HEPATITIS-C
    SANGIOVANNI, A
    SPINZI, GC
    BISSOLI, F
    COLOMBO, E
    RAINER, H
    COLLI, A
    CASIRAGHI, A
    FOSSATI, M
    ROCCA, F
    MINOLI, G
    [J]. GASTROENTEROLOGY, 1993, 104 (04) : A984 - A984
  • [23] ALPHA-LYMPHOBLASTOID INTERFERON (A-LY-IFN) THERAPY IN 12 CHILDREN WITH CHRONIC HEPATITIS-C (CHC)
    IORIO, R
    FARIELLO, I
    GUIDA, S
    PENSATI, P
    ARANEO, P
    VEGNENTE, A
    [J]. HEPATOLOGY, 1993, 18 (04) : A237 - A237
  • [24] INTERFERON-(IFN-)TREATMENT (RECOMBINANT IFN-ALPHA-2C OR RECOMBINANT IFN-GAMMA) OF METASTASIZED RENAL-CELL CARCINOMA
    KUZMITS, R
    SCHEITHAUER, W
    LUDWIG, H
    FLENER, R
    [J]. ACTA MEDICA AUSTRIACA, 1985, 12 (05) : 129 - 134
  • [25] PROLONGATION OF DAILY ADMINISTRATION OF INTERFERON (IFN)-ALPHA-2A IN PATIENTS WITH CHRONIC HEPATITIS-C (CHC) - EFFICACY AND FEATURES PREDICTIVE OF RESPONSE TO IFN
    OKAZAKI, T
    HAYAKAWA, Y
    HIGASHI, T
    MUKUDA, T
    ARAI, K
    YAMADA, Y
    SUZUKI, K
    YOSHIHARA, H
    [J]. GASTROENTEROLOGY, 1995, 108 (04) : A1137 - A1137
  • [26] Cognitive impairment in patients with chronic hepatitis treated with interferon alpha (IFNα):: results from a prospective study
    Lieb, K
    Engelbrecht, MA
    Gut, O
    Fiebich, BL
    Bauer, J
    Janssen, G
    Schaefer, M
    [J]. EUROPEAN PSYCHIATRY, 2006, 21 (03) : 204 - 210
  • [27] Lymphoblastoid α-IFN, leukocytic α-IFN and natural β-IFN in the treatment of chronic hepatitis C:: a clinical comparison of 150 cases
    Cecere, A
    Romano, C
    Caiazzo, R
    Lucariello, A
    Tancredi, L
    Gattoni, A
    [J]. HEPATOLOGY RESEARCH, 1999, 15 (03) : 225 - 237
  • [28] PREDICTORS OF RESPONSE TO INTERFERON-ALPHA (IFN) THERAPY IN CHRONIC HEPATITIS-C
    BENNETT, WG
    ORITO, E
    MIZOKAM, M
    LA, JYN
    [J]. GASTROENTEROLOGY, 1995, 108 (04) : A1034 - A1034
  • [29] Randomized, controlled trial with interferon-alpha (IFN-alpha) combined with ribavirin with and without amantadine sulfate in primary IFN-alpha nonresponsive patients with chronic hepatitis C
    Teuber, G
    Berg, T
    Lafrenz, M
    Weidenbach, H
    Schoelmerich, J
    Wietzke-Braun, P
    Pausch, J
    Arnold, R
    Lock, G
    Hopf, U
    Zeuzem, S
    [J]. JOURNAL OF HEPATOLOGY, 2001, 34 : 23 - 23
  • [30] Effect of alpha interferon (IFN-alpha) on 2'-5' oligoadenylate synthetase activity in peripheral blood mononuclear cells of patients with chronic hepatitis C: Relationship to the antiviral effect of IFN-alpha
    Pawlotsky, JM
    Hovanessian, AG
    RoudotThoraval, F
    Robert, N
    Bouvier, M
    Babany, G
    Duval, J
    Dhumeaux, D
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (02) : 320 - 324
12345